Fasxiator, a novel factor XIa inhibitor from snake venom, and its site‐specific mutagenesis to improve potency and selectivity

Publisher： John Wiley & Sons Inc

E-ISSN： 1538-7836|13|2|248-261

ISSN： 1538-7933

Source： JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol.13, Iss.2, 2015-02, pp. : 248-261

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Snake Venom Activators of Factor X: An Overview

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 31, Iss. 3-6, 2002-03 ,pp. : 225-233

Karger

Access to resources Recommend Favorite

A novel snake venom‐derived GPIb antagonist, anfibatide, protects mice from acute experimental ischaemic stroke and reperfusion injury

By  

BRITISH JOURNAL OF PHARMACOLOGY (ELECTRONIC), Vol. 172, Iss. 15, 2015-08 ,pp. : 3904-3916

John Wiley & Sons Inc

Access to resources Recommend Favorite

Carcinogen-Induced Site-Specific Mutagenesis and Genetic Susceptibility in Squamous Cell Carcinoma of the Head and Neck

By  

Oncology Research and Treatment, Vol. 25, Iss. 1, 2002-03 ,pp. : 8-13

Karger

Access to resources Recommend Favorite

Snake Venom Prothrombin Activators Homologous to Blood Coagulation Factor Xa

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 31, Iss. 3-6, 2002-03 ,pp. : 234-240

Karger

Access to resources Recommend Favorite

Diagnostic Uses of Snake Venom

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 31, Iss. 3-6, 2002-03 ,pp. : 211-217

Karger

Access to resources Recommend Favorite